Dietary supplements don’t undergo the Food and Drug Administration’s rigorous approval process required for drugs, the suit says. A diet supplement label making certain claims about its effect on the body must have a disclaimer saying the FDA hasn’t evaluated the statements and that the product isn’t intended to diagnose, treat, cure, or prevent any disease, the suit says.
Amazon and its partners systematically promote products lacking the mandatory disclaimers, making the supplements unapproved drugs that can’t ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.